Showing results (11-20 of 81) with videos related to
Sort By:
Pageof 9
Breathe (Sheffield, England)|November 7, 2022
Beyond antibiotics: recent developments in the diagnosis and management of nontuberculous mycobacterial infectionLaura E Gleeson, Grant WatererRespirology (Carlton, Vic.)|May 30, 2013
Healthcare-associated pneumonia: a US disease or relevant to the Asia Pacific, too?Claudia C Dobler, Grant WatererTherapeutic Advances in Respiratory Disease|February 20, 2016
Inhaled corticosteroids and the increased risk of pneumonia: what's new? A 2015 updated reviewHernan Iannella, Carlos Luna, Grant WatererCritical Care Medicine|December 18, 2010
We should be measuring genomic bacterial load and virulence factorsThiago Lisboa, Grant Waterer, Jordi RelloCurrent Opinion in Critical Care|August 29, 2023
Severe community-acquired pneumonia in the post COVID-19 eraAlfonsina Ruiz-Spinelli, Grant Waterer, Jordi RelloTherapeutic Advances in Respiratory Disease|June 10, 2010
Can immunogenetics illuminate the diverse manifestations of respiratory infections?Jacquita S Affandi, Patricia Price, Grant WatererJournal of Renal Care|May 21, 2013
Patient independence in chronic kidney disease and anaemia: implications of the 2012 KDIGO guidelineLesley BennettAntimicrobial Agents and Chemotherapy|January 23, 2020
Phase I, Dose-Escalating Study of the Safety and Pharmacokinetics of Inhaled Dry-Powder Vancomycin (AeroVanc) in Volunteers and Patients with Cystic Fibrosis: a New Approach to Therapy for Methicillin-Resistant Staphylococcus aureusGrant Waterer, John Lord, Thomas Hofmann, et al.Clinical Immunology (Orlando, Fla.)|August 28, 2010
Susceptibility to pulmonary disease due to Mycobacterium avium-intracellulare complex may reflect low IL-17 and high IL-10 responses rather than Th1 deficiencyAndrew Lim, Caris Allison, Patricia Price, et al.Pageof 9